Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosignoli

Showing results (291-300 of 300) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 300 results.
Nature Medicine|August 21, 2025
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trialFranco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Unravelling the role of epigenetic regulators during embryonic development of <i>Rhipicephalus microplus</i>Anderson Mendonça Amarante, Daniel Martins de Oliveira, Marcos Paulo Nicolich Camargo de Souza, et al.
Nature Medicine|September 9, 2025
Publisher Correction: GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trialFranco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
International Journal of Molecular Sciences|September 27, 2025
Unraveling the Roles of Epigenetic Regulators During the Embryonic Development of <i>Rhipicephalus microplus</i>Anderson Mendonça Amarante, Daniel Martins de Oliveira, Marcos Paulo Nicolich Camargo de Souza, et al.
The Journal of Headache and Pain|December 3, 2024
Resistant and refractory migraine - two different entities with different comorbidities? Results from the REFINE studyC Rosignoli, R Ornello, V Caponnetto, et al.
Cephalalgia : an International Journal of Headache|June 5, 2026
Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine - data from the REFINE studyFederico De Santis, Chiara Rosignoli, Agnese Onofri, et al.
Nature Medicine|February 5, 2026
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseasesMarco Becilli, Markus Metzler, Claudia Bracaglia, et al.
The Journal of Headache and Pain|August 15, 2025
Longitudinal assessment of migraine burden in resistant and refractory migraine - Data from the prospective REFINE studyUmberto Pensato, Raffaele Ornello, Chiara Rosignoli, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2022
Root angle is controlled by <i>EGT1</i> in cereal crops employing an antigravitropic mechanismRiccardo Fusi, Serena Rosignoli, Haoyu Lou, et al.
American Journal of Hematology|November 26, 2025
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 StudyNicola Polverelli, Caterina Zerbi, Maria Grazia Benevento, et al.
Pageof 30

Showing results (291-300 of 300) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 300 results.
Nature Medicine|August 21, 2025
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trialFranco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Unravelling the role of epigenetic regulators during embryonic development of <i>Rhipicephalus microplus</i>Anderson Mendonça Amarante, Daniel Martins de Oliveira, Marcos Paulo Nicolich Camargo de Souza, et al.
Nature Medicine|September 9, 2025
Publisher Correction: GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trialFranco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
International Journal of Molecular Sciences|September 27, 2025
Unraveling the Roles of Epigenetic Regulators During the Embryonic Development of <i>Rhipicephalus microplus</i>Anderson Mendonça Amarante, Daniel Martins de Oliveira, Marcos Paulo Nicolich Camargo de Souza, et al.
The Journal of Headache and Pain|December 3, 2024
Resistant and refractory migraine - two different entities with different comorbidities? Results from the REFINE studyC Rosignoli, R Ornello, V Caponnetto, et al.
Cephalalgia : an International Journal of Headache|June 5, 2026
Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine - data from the REFINE studyFederico De Santis, Chiara Rosignoli, Agnese Onofri, et al.
Nature Medicine|February 5, 2026
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseasesMarco Becilli, Markus Metzler, Claudia Bracaglia, et al.
The Journal of Headache and Pain|August 15, 2025
Longitudinal assessment of migraine burden in resistant and refractory migraine - Data from the prospective REFINE studyUmberto Pensato, Raffaele Ornello, Chiara Rosignoli, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2022
Root angle is controlled by <i>EGT1</i> in cereal crops employing an antigravitropic mechanismRiccardo Fusi, Serena Rosignoli, Haoyu Lou, et al.
American Journal of Hematology|November 26, 2025
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 StudyNicola Polverelli, Caterina Zerbi, Maria Grazia Benevento, et al.
Pageof 30